Dopamine
Patient-specific bag-prep worksheet for a 100 mL dopamine drip. The 6×kg shortcut adds 6 mg/kg of stock to a 100 mL bag, yielding a concentration where the pump rate in mL/hr equals the dose in µg/kg/min. No further math at the bedside. Used for inotropic and vasopressor support in hypotension and shock once fluid status is adequate.
- High-alert medication. Do NOT confuse DOPamine with DOBUTamine or DOXapram (Doprap).
- Volume status first. Volume depletion should be corrected before dopamine administration. Vasopressors are not a substitute for adequate fluid replacement.
Uses the 6 × kg method: add (6 × patient weight in kg) mg of dopamine to a 100 mL bag of compatible IV fluid. Once mixed, the pump rate in mL/hr is equal to the dose in µg/kg/min, no further math at the bedside.
Don't have a 100 mL bag? The 6×kg shortcut requires a 100 mL bag specifically (the elegant pump-rate-equals-dose identity is bag-size dependent). If you only have 250 mL or 500 mL bags available, use the standard dopamine CRI calculator →
Enter a patient weight to see the result.
How the calculation works
The 6 × kg method produces a bag where pump rate (mL/hr) equals dose (µg/kg/min). The bag concentration is derived as:
At that concentration, a dose of D µg/kg/min requires:
So pump rate (mL/hr) and dose (µg/kg/min) are numerically equal, no further bedside math needed.
Worked example with current inputs
Enter a patient weight to see the worked example.
Enter a patient weight to see the worked example.
The 6 × kg method
The preparation worksheet specifies:
- Multiply patient weight in kg by 6, that's the milligrams of dopamine to add.
- From a 40 mg/mL stock vial, draw the equivalent volume.
- Remove that same volume from a 100 mL bag of compatible IV fluid first, then add the dopamine.
- Run the pump at mL/hr = dose in µg/kg/min.
Worked example
For a 10 kg patient: 6 × 10 = 60 mg of dopamine, which is 1.5 mL of 40 mg/mL stock. Remove 1.5 mL from a 100 mL bag, then add 1.5 mL of dopamine. To dose at 5 µg/kg/min, run the pump at 5 mL/hr.
Why this works
A 100 mL bag with (6 × BW) mg of dopamine has concentration (6 × BW × 1000) ÷ 100 = 60 × BW µg/mL. For a dose D µg/kg/min, total drug needed per hour is BW × D × 60 µg. Divided by the concentration: (60 × BW × D) ÷ (60 × BW) = D mL/hr.
Limits and stability
- The final dopamine concentration is capped at 3,200 µg/mL (3.2 mg/mL). The 6 × kg method exceeds this for patients above ~53 kg; at that point, switch to a 250 mL or 500 mL bag with proportionally more dopamine.
- Stable for 24 hours at 20–25°C after dilution. Discard if discolored beyond slightly yellow.
- Administer through a dedicated IV line into a large vein. Extravasation causes tissue necrosis.
- Stepwise dose reduction prior to discontinuation reduces rebound hypotension risk.
Compatible fluids
5% / 10% dextrose, lactated Ringer's, 5% dextrose in LRS or 0.9% NaCl, 6% hetastarch, Plasma-Lyte, 0.9% NaCl.
Contraindications and cautions
- Contraindicated: pheochromocytoma, ventricular fibrillation, uncorrected tachyarrhythmias.
- Caution: ischemic or occlusive vascular disease; weaning from mechanical ventilation; oliguric acute kidney injury (low-dose dopamine is unlikely to benefit and may worsen renal vasoconstriction).
- Discontinue or reduce dose if PVCs occur or if there are signs of reduced peripheral or cardiac perfusion.
Notable drug interactions
- α-antagonists (acepromazine, prazosin): may decrease pressor effects.
- β-antagonists (propranolol, metoprolol): combination causes unopposed α stimulation, raising SVR.
- Inhalant anesthetics (isoflurane, sevoflurane): may increase arrhythmia risk.
- MAOIs (amitraz, selegiline, linezolid): start dopamine at 1/10 the usual dose if MAOI given within 2–3 weeks.
- Other sympathomimetics (dobutamine, terbutaline, etc.): toxicity risk if combined.
Sources
- Primary: Plumb's Veterinary Drugs, dopamine monograph (Prescriber Highlights, Pharmacology/Actions, Pharmacokinetics, Contraindications/Precautions/Warnings, Adverse Effects, Drug Interactions, Dosages, Preparation/Stability, Administration sections).
- Secondary (cat HCM/PVC concern): Lumb and Jones' Veterinary Anesthesia and Analgesia, 6th ed. Chapter 21 (Cardiovascular Drugs). Editor and full bibliographic details pending.
- Secondary (clinical positioning): Hart S, Silverstein DC. Catecholamines. In: Silverstein DC, Hopper K, eds. Small Animal Critical Care Medicine. 3rd ed. St. Louis, MO: Elsevier; 2023:855–859 (Chapter 147, Table 147.1). Confirms the receptor-effect dose tiers (1–4 µg/kg/min dopaminergic; 5–10 µg/kg/min β; >10 µg/kg/min α) and provides the clinical context that dopamine is currently recommended as an alternative to norepinephrine only in highly selected patients (low risk of tachyarrhythmias, or absolute/relative bradycardia), its use in critically ill humans has been associated with significantly poorer outcomes and higher arrhythmic-event incidence than norepinephrine.